Status:

ACTIVE_NOT_RECRUITING

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

Lead Sponsor:

Leiden University Medical Center

Collaborating Sponsors:

Dutch Cancer Society

Comprehensive Cancer Centre The Netherlands

Conditions:

Endometrial Cancer Stage I

Endometrial Cancer Stage II

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

This is prospective, multicenter, randomised phase III trial among women with endometrial cancer with high-intermediate risk features to investigate the role of an integrated clinicopathological and m...

Detailed Description

Adjuvant therapy for women with endometrial cancer has increasingly been tailored to prognostic factors to prevent overtreatment and select those women for adjuvant treatment who will have a clinicall...

Eligibility Criteria

Inclusion

  • Histologically confirmed endometrioid type endometrial carcinoma, International Federation of Gynecology and Obstetrics (FIGO) 2009 stage I, with one of the following combinations of stage, grade, age, and lymph-vascular space invasion (LVSI):
  • Stage IA, grade 3 (any age, with or without LVSI)
  • Stage IB, grade 1 or 2 and age \>60 years
  • Stage IB, grade 1-2 with documented LVSI
  • Stage IB, grade 3 without LVSI
  • Stage II (microscopic), grade 1
  • World Health Organization (WHO)-performance status 0-2
  • Written informed consent

Exclusion

  • Any other stage and type of endometrial carcinoma
  • Histological types serous carcinoma or clear cell carcinoma (at least 10% if mixed type), or undifferentiated or neuroendocrine carcinoma
  • Uterine sarcoma (including carcinosarcoma)
  • Previous malignancy (except for non-melanomatous skin cancer) \< 5 yrs
  • Previous pelvic radiotherapy
  • Expected interval between the operation and start of radiotherapy exceeding 8 weeks

Key Trial Info

Start Date :

June 10 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2028

Estimated Enrollment :

550 Patients enrolled

Trial Details

Trial ID

NCT03469674

Start Date

June 10 2016

End Date

December 31 2028

Last Update

October 11 2023

Active Locations (31)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (31 locations)

1

Medical University, Vienna

Vienna, Austria

2

University Hospital Gent

Ghent, Belgium

3

CEEGOG, General Faculty Hospital and First Faculty of Medicine, Charles University, Prague

Prague, Czechia

4

GINECO group - Institut Goustave Roussy

Paris, France